These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11097270)

  • 21. Comparative pharmacological profiles of morphine and oxycodone under a neuropathic pain-like state in mice: evidence for less sensitivity to morphine.
    Narita M; Nakamura A; Ozaki M; Imai S; Miyoshi K; Suzuki M; Suzuki T
    Neuropsychopharmacology; 2008 Apr; 33(5):1097-112. PubMed ID: 17593930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effects of sulfated cholecystokinin octapeptide and proglumide injected intrathecally on antinociception induced by beta-endorphin and morphine administered intracerebroventricularly in mice.
    Suh HH; Tseng LF
    Eur J Pharmacol; 1990 Apr; 179(3):329-38. PubMed ID: 2142090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of spinal cholecystokinin receptor antagonists on morphine antinociception in a model of visceral pain in the rat.
    Friedrich AE; Gebhart GF
    J Pharmacol Exp Ther; 2000 Feb; 292(2):538-44. PubMed ID: 10640290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic administration of cholecystokinin antagonists reverses the enhancement of spinal morphine analgesia induced by acute pretreatment.
    Kellstein DE; Mayer DJ
    Brain Res; 1990 May; 516(2):263-70. PubMed ID: 2364292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition by spinal morphine of the tail-flick response is attenuated in rats with nerve ligation injury.
    Ossipov MH; Lopez Y; Nichols ML; Bian D; Porreca F
    Neurosci Lett; 1995 Oct; 199(2):83-6. PubMed ID: 8584249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Caerulein and morphine: an attempt to differentiate their antinociceptive effects.
    Zetler G
    Pharmacology; 1982; 25(3):121-9. PubMed ID: 7146080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of CCK antagonists on GABA mechanism-induced antinociception in the formalin test.
    Rezayat M; Tabarrai E; Parvini S; Zarrindast MR; Pirali M
    Eur Neuropsychopharmacol; 1999 Jan; 9(1-2):9-14. PubMed ID: 10082222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions between antinociception induced by cholecystokinin antagonists and GABA agonists in the tail-flick test.
    Zarrindast MR; Rezayat M; Ghanipoor N; Parvini S
    Pharmacol Toxicol; 1998 Oct; 83(4):143-8. PubMed ID: 9820874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The novel CCK antagonist L364,718 abolished caerulein- but potentiates morphine-induced antinociception.
    Rattray M; Jordan CC; De Belleroche J
    Eur J Pharmacol; 1988 Jul; 152(1-2):163-6. PubMed ID: 3208830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of intracerebroventricular and systemic injections of caerulein, a CCK analogue, on electrical self-stimulation and its interaction with the CCKA receptor antagonist, L-364,718 (MK-329).
    Hamilton MH; Rose IC; Herberg LJ; de Belleroche JS
    Psychopharmacology (Berl); 1990; 101(3):384-9. PubMed ID: 2362955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic antinociceptive interactions of morphine and clonidine in rats with nerve-ligation injury.
    Ossipov MH; Lopez Y; Bian D; Nichols ML; Porreca F
    Anesthesiology; 1997 Jan; 86(1):196-204. PubMed ID: 9009955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of CCK caerulein, and CCK antagonists in nociception.
    Baber NS; Dourish CT; Hill DR
    Pain; 1989 Dec; 39(3):307-328. PubMed ID: 2694075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pretreatment with antiserum against dynorphin, substance P, or cholecystokinin enhances the morphine-produced anti-allodynia in the sciatic nerve ligated mice.
    Wu HE; Schwasinger ET; Hong JS; Tseng LF
    Neurosci Lett; 2005 Sep; 386(1):46-51. PubMed ID: 15982809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of cholecystokinin analogue caerulein and cholecystokinin antagonist lorglumide on pancreatic carcinogenesis in the rat.
    Sperti C; Militello C; Rovati L; Behboo R; Khajeturian E; Perasole A; Alaggio R; Pedrazzoli S
    J Surg Oncol; 1994 Sep; 57(1):11-6. PubMed ID: 8065144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CCK receptor activation may prevent tolerance to morphine in mice.
    Rezayat M; Nikfar S; Zarrindast MR
    Eur J Pharmacol; 1994 Mar; 254(1-2):21-6. PubMed ID: 8206114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential activities of intrathecal MK-801 or morphine to alter responses to thermal and mechanical stimuli in normal or nerve-injured rats.
    Wegert S; Ossipov MH; Nichols ML; Bian D; Vanderah TW; Malan TP; Porreca F
    Pain; 1997 May; 71(1):57-64. PubMed ID: 9200174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Caerulein-induced acute necrotizing pancreatitis in mice: protective effects of proglumide, benzotript, and secretin.
    Niederau C; Ferrell LD; Grendell JH
    Gastroenterology; 1985 May; 88(5 Pt 1):1192-204. PubMed ID: 2984080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Midazolam attenuates the antinociception induced by d-serine or morphine at the supraspinal level in rats.
    Ito K; Yoshikawa M; Maeda M; Jin XL; Takahashi S; Matsuda M; Tamaki R; Kobayashi H; Suzuki T; Hashimoto A
    Eur J Pharmacol; 2008 May; 586(1-3):139-44. PubMed ID: 18384770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of extracellular signal-regulated kinase in the ventral tegmental area in the suppression of the morphine-induced rewarding effect in mice with sciatic nerve ligation.
    Ozaki S; Narita M; Narita M; Ozaki M; Khotib J; Suzuki T
    J Neurochem; 2004 Mar; 88(6):1389-97. PubMed ID: 15009639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripheral participation of cholecystokinin in the morphine-induced peripheral antinociceptive effect in non-diabetic and diabetic rats.
    Torres-López JE; Juárez-Rojop IE; Granados-Soto V; Diaz-Zagoya JC; Flores-Murrieta FJ; Ortíz-López JU; Cruz-Vera J
    Neuropharmacology; 2007 Mar; 52(3):788-95. PubMed ID: 17157334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.